R. Brown

发表

High-dose N,N',N"-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studies.

J. Fay, P. Coccia, C. Lemaistre, 1990, Seminars in oncology.

A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients.

E. Shpall, T. Shea, G. Long, 1999, Blood.

Outcomes of high-dose chemotherapy and autologous stem-cell transplantation in stage IIIB inflammatory breast cancer.

R. Vij, K. Trinkaus, P. Fracasso, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Essential thrombocythemia after allogeneic bone marrow transplantation for chronic myelogenous leukemia

B. Zehnbauer, D. Adkins, L. Goodnough, 1998, Bone Marrow Transplantation.

Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: graft-versus-host disease and transplant-related mortality.

R. Vij, J. Dipersio, D. Adkins, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone

R. Vij, M. Tomasson, K. Trinkaus, 2005, Bone Marrow Transplantation.

Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes

M. Rich, R. Vij, M. Tomasson, 2004, Bone Marrow Transplantation.

Low-dose (550 cGy), single-exposure total body irradiation and cyclophosphamide: consistent, durable engraftment of related-donor peripheral blood stem cells with low treatment-related mortality and fatal organ toxicity.

R. Vij, P. Westervelt, J. Dipersio, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant Group.

R. Collins, J. Fay, J. Lynch, 1999, Leukemia & lymphoma.

Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation.

R. Vij, D. Adkins, L. Goodnough, 2000, Blood.

Association between a functional polymorphism in Toll‐like receptor 3 and chronic hepatitis C in liver transplant recipients

R. Razonable, R. Brown, S-O Lee, 2013, Transplant infectious disease : an official journal of the Transplantation Society.

Autologous Peripheral Blood Progenitor Cell Transplantation in Multiple Myeloma

H. Rugo, J. Dipersio, G. Schiller, 1999 .

Donor-derived acute promyelocytic leukemia in a liver-transplant recipient.

J. Radich, D. Adkins, M. Peters, 1999, The New England journal of medicine.

Innovations in allogeneic stem-cell transplantation.

R. Vij, J. Dipersio, D. Adkins, 2000, Seminars in hematology.

Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies.

J. Dipersio, D. Adkins, L. Goodnough, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Unstable angina in a peripheral blood stem and progenitor cell donor given granulocyte–colony‐stimulating factor

R. Vij, J. Dipersio, D. Adkins, 1999, Transfusion.

Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial.

H. Rugo, P. Stiff, K. Anderson, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity?

R. Vij, K. Trinkaus, J. Dipersio, 2000, Bone Marrow Transplantation.

Outcomes of high-dose chemotherapy and autologous stem cell transplant in isolated locally recurrent breast cancer: a multicenter evaluation

R. Vij, K. Trinkaus, J. Dipersio, 2000, Bone Marrow Transplantation.

Patient selection in high-dose trials of breast cancer.

J. Dipersio, D. Adkins, R. Brown, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Purine analog regimens for allogeneic transplant?

D. Adkins, L. Goodnough, J. DiPersio, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.

R. Vij, J. Dipersio, C. Hallemeier, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with a low-dose (550 cGy) total body irradiation conditioning regimen.

R. Vij, K. Trinkaus, P. Westervelt, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide.

T. Ley, P. Westervelt, J. Dipersio, 2001, Blood.

Kinetics of interferon‐gamma producing cytomegalovirus (CMV)‐specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation

J. Eckel-Passow, W. Hogan, M. Litzow, 2009, Transplant infectious disease : an official journal of the Transplantation Society.

High-Dose Weekly Intravenous Immunoglobulin to Prevent Infections in Patients Undergoing Autologous Bone Marrow Transplantation or Severe Myelosuppressive Therapy: A Study of the American Bone Marrow Transplant Group

R. Collins, J. Fay, J. Greer, 1993, Annals of Internal Medicine.

Histological criteria for the identification of acute cellular rejection in human small bowel allografts: results of the pathology workshop at the VIII International Small Bowel Transplant Symposium.

N. Harpaz, J. Reyes, P. Ruiz, 2004, Transplantation proceedings.

Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation

R. Vij, K. Trinkaus, P. Westervelt, 2000, Bone Marrow Transplantation.

Cerebellar toxicity with high-dose cytosine arabinoside.

H. Lazarus, P. Coccia, D. Adelstein, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hydroxychloroquine for the prevention of acute graft-versus-host disease after unrelated donor transplantation.

R. Vij, K. Trinkaus, H. McLeod, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults.

D. Reece, R. Herzig, M. Barnett, 1991, Blood.

High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group.

R. Collins, J. Fay, J. Lynch, 1996, Leukemia & lymphoma.

High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant Group.

R. Collins, J. Fay, J. Lynch, 1995, Blood.

Bone marrow transplantation for childhood acute lymphoblastic leukaemia after marrow relapse

H. Mameghan, G. Marshall, A. Trickett, 1990, The Medical journal of Australia.